等待开盘 03-26 09:30:00 美东时间
0.000
0.00%
BRIEF-Yimutian Inc. Provides Updates On Its Financing Plan Yimutian Inc YMT.O : YIMUTIAN INC. PROVIDES UPDATES ON ITS FINANCING PLAN YIMUTIAN INC - WILL NOT PROCEED WITH PROPOSED FOLLOW-ON PUBLIC OFFERING FILED FEB 23, 2026 YIMUTIAN INC - TO WITHDRAW REGISTRATION STATEMENT AND TERMINATE PROPOSED OFF
03-25 21:16
BRIEF-Empery Digital Announces $25 Million Registered Direct Offering Empery Digital Inc EMPD.O : EMPERY DIGITAL ANNOUNCES $25 MILLION REGISTERED DIRECT OFFERING EMPERY DIGITAL INC - NET PROCEEDS TO REDUCE DEBT BY $40 MILLION INCLUDING FULL REPAYMENT OF $50 MILLION REPO FACILITY Source text: ID:nBwb
03-23 20:49
BRIEF-Parazero Technologies Ltd. Announces $4 Million Registered Direct Offering Parazero Technologies Ltd PRZO.O : PARAZERO TECHNOLOGIES LTD. ANNOUNCES $4 MILLION REGISTERED DIRECT OFFERING PARAZERO TECHNOLOGIES LTD - ANNOUNCES $4 MILLION REGISTERED DIRECT OFFERING AT $0.75 PER SHARE Source text: I
03-23 20:35
BRIEF-Vivopower Terminates $180 Million F-3 Registration Statement March 18 (Reuters) - VivoPower PLC VIVO.O : VIVOPOWER TERMINATES $180 MILLION F-3 REGISTRATION STATEMENT VIVOPOWER PLC - NO FURTHER SALES OF ORDINARY SHARES UNDER F-3 REGISTRATION STATEMENT Source text: ID:nGNX8PDJF4 Further company
03-18 21:01
BRIEF-Enveric Biosciences Announces Registration Of Five Trademarks March 18 (Reuters) - Enveric Biosciences Inc ENVB.O : ENVERIC BIOSCIENCES ANNOUNCES REGISTRATION OF FIVE TRADEMARKS Source text: ID:nBw5k8BqTa Further company coverage: ENVB.O (( Reuters.Briefs@thomsonreuters.com ;))
03-18 20:02
随着中东战火引发全球原油供应链危机,美国正以前所未有的“借贷”形式释放战略石油储备,华尔街的原油交易员们迅速调整策略……
03-18 08:33
BRIEF-Regis Corporation Announces Executive Leadership And Board Appointments March 16 (Reuters) - Regis Corp RGS.O : REGIS CORPORATION ANNOUNCES EXECUTIVE LEADERSHIP AND BOARD APPOINTMENTS REGIS CORP - APPOINTS SUSAN LINTONSMITH AS CHIEF EXECUTIVE OFFICER REGIS CORP - APPOINTS NANCY BENACCI AS CHAI
03-16 21:02
BRIEF-NovaBridge Announces Productive FDA Type B Meeting On Potential Accelerated Approval Pathway For Givastomig In Gastric Cancer March 16 (Reuters) - NovaBridge Biosciences NBP.O : NOVABRIDGE ANNOUNCES PRODUCTIVE FDA TYPE B MEETING ON POTENTIAL ACCELERATED APPROVAL PATHWAY FOR GIVASTOMIG IN GASTR
03-16 19:36
Phio Pharmaceuticals to present at the Life Sciences Investor Forum at 11 a.m. ET Phio will present at the Life Sciences Investor Forum on March 12, 2026 at 11:00 AM ET via VirtualInvestorConferences.com. Registration is available at REGISTER HERE . The company will also offer 1x1 meetings on March
03-10 19:16